Article

Broadly neutralizing SARS-CoV-2 antibodies through epitope-based selection from convalescent patients

2022-10-20

Abstract excerpt

<h4>SUMMARY</h4> Emerging variants of concern (VOCs) are threatening to limit the effectiveness of SARS-CoV-2 monoclonal antibodies and vaccines currently used in clinical practice; broadly neutralizing antibodies and strategies for their identification are therefore urgently required. Here we demonstrate that broadly neutralizing antibodies can be isolated from peripheral blood mononuclear cells (PBMCs) of conva...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: c24ba486-7e45-51d3-a241-22453a7df86e
DOI: 10.1101/2022.10.19.512954

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Broadly neutralizing SARS-CoV-2 antibodies through epitope-based selection from convalescent patientsDOI 10.1101/2022.10.19.512954Read

Broadly neutralizing antibodies overcome SARS-CoV-2 Omicron antigenic shiftSemantic proximity Read

Broadly-Neutralizing Antibodies Against Emerging SARS-CoV-2 Variants.Semantic proximity Read

Elucidating the Humoral Immune Response to SARS-CoV-2: Isolation and Characterization of Monoclonal Antibodies from Convalescent COVID-19 PatientsSemantic proximity Read

A public vaccine-induced human antibody protects against SARS-CoV-2 and emerging variantsSemantic proximity Read

Potent neutralization by a RBD antibody with broad specificity for SARS-CoV-2 JN.1 and other variantsSemantic proximity Read

An ACE2-blocking antibody confers broad neutralization and protection against Omicron and other SARS-CoV-2 variantsSemantic proximity Read

Characterization of neutralizing antibodies from a SARS-CoV-2 infected individualSemantic proximity Read

Fortuitous Somatic Mutations during Antibody Evolution Endow Broad Neutralization against SARS-CoV-2 Omicron VariantsSemantic proximity Read

Comprehensive Mapping of Binding Hot Spots of SARS-CoV-2 RBD-specific Neutralizing Antibodies for Tracking Immune Escape VariantsSemantic proximity Read

Development of Fully Human, Bispecific Antibodies that Effectively Block Omicron Variant Pseudovirus InfectionsSemantic proximity Read

Preclinial Safety and Efficacy of a Therapeutic Antibody That Targets SARS-CoV-2 at the Sotrovimab Face But is Escaped by OmicronSemantic proximity Read

A potently neutralizing anti-SARS-CoV-2 antibody inhibits variants of concern by binding a highly conserved epitopeSemantic proximity Read